CARDINAL HEALTH ($CAH) posted quarterly earnings results for Q2 2026 on Thursday, February 5th. The company reported earnings of $2.63 per share, beating estimates of $2.38 by $0.25. The company also reported revenue of $65,627,000,000, beating estimates of $64,785,100,811 by $841,899,189.
You can see Quiver Quantitative's $CAH stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
CARDINAL HEALTH Insider Trading Activity
CARDINAL HEALTH insiders have traded $CAH stock on the open market 19 times in the past 6 months. Of those trades, 0 have been purchases and 19 have been sales.
Here’s a breakdown of recent trading of $CAH stock by insiders over the last 6 months:
- JASON M. HOLLAR (Chief Executive Officer) has made 0 purchases and 5 sales selling 143,606 shares for an estimated $21,424,215.
- AARON E ALT (Chief Financial Officer) has made 0 purchases and 2 sales selling 48,243 shares for an estimated $7,177,389.
- STEPHEN M MASON (CEO, GMPD Segment) has made 0 purchases and 3 sales selling 41,575 shares for an estimated $6,187,063.
- JESSICA L MAYER (Chief Legal/Compliance Officer) has made 0 purchases and 3 sales selling 38,078 shares for an estimated $5,666,832.
- OLA M SNOW (Chief Human Resources Officer) has made 0 purchases and 2 sales selling 28,151 shares for an estimated $4,192,916.
- DEBORAH WEITZMAN (CEO, PSS Segment) sold 21,367 shares for an estimated $3,216,374
- MICHELLE D. GREENE (Chief Information Officer) has made 0 purchases and 2 sales selling 13,500 shares for an estimated $2,009,043.
- MARY C. SCHERER (Chief Accounting Officer) sold 6,766 shares for an estimated $1,009,825
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
CARDINAL HEALTH Hedge Fund Activity
We have seen 612 institutional investors add shares of CARDINAL HEALTH stock to their portfolio, and 581 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- WELLINGTON MANAGEMENT GROUP LLP added 3,511,579 shares (+153.2%) to their portfolio in Q3 2025, for an estimated $551,177,439
- UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC added 2,449,400 shares (+94.9%) to their portfolio in Q3 2025, for an estimated $384,457,824
- MARSHALL WACE, LLP removed 1,864,356 shares (-96.6%) from their portfolio in Q3 2025, for an estimated $292,629,317
- HOLOCENE ADVISORS, LP added 1,128,358 shares (+141.4%) to their portfolio in Q3 2025, for an estimated $177,107,071
- BLACKROCK, INC. added 916,791 shares (+3.0%) to their portfolio in Q3 2025, for an estimated $143,899,515
- FMR LLC removed 854,880 shares (-13.6%) from their portfolio in Q3 2025, for an estimated $134,181,964
- PACER ADVISORS, INC. removed 853,158 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $175,323,969
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
CARDINAL HEALTH Government Contracts
We have seen $229,008,139 of award payments to $CAH over the last year.
Here are some of the awards which we have have seen pay out the most over the last year:
- EXPRESS REPORT: MEDICAL SURGICAL PRIME VENDOR EXPENDITURES FOR THE MONTH OF APRIL 2025.: $10,194,510
- EXPRESS REPORT: MEDICAL SURGICAL PRIME VENDOR EXPENDITURES FOR THE MONTH OF JANUARY 2025: $9,899,536
- EXPRESS REPORT: MEDICAL SURGICAL PRIME VENDOR EXPENDITURES FOR THE MONTH OF MARCH 2025: $9,596,571
- EXPRESS REPORT: MEDICAL SURGICAL PRIME VENDOR EXPENDITURES FOR THE MONTH OF FEBRUARY 2025: $8,571,978
- EXPRESS REPORT: MSPV EXPENDITURES FOR MAY 2025: $4,117,385
To track government contracts to publicy traded companies, check out Quiver Quantitative's government contracts dashboard.
CARDINAL HEALTH Congressional Stock Trading
Members of Congress have traded $CAH stock 1 times in the past 6 months. Of those trades, 1 have been purchases and 0 have been sales.
Here’s a breakdown of recent trading of $CAH stock by members of Congress over the last 6 months:
- REPRESENTATIVE MARJORIE TAYLOR GREENE purchased up to $15,000 on 10/24.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
CARDINAL HEALTH Analyst Ratings
Wall Street analysts have issued reports on $CAH in the last several months. We have seen 5 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Morgan Stanley issued a "Overweight" rating on 01/29/2026
- Mizuho issued a "Outperform" rating on 11/04/2025
- TD Cowen issued a "Buy" rating on 11/03/2025
- UBS issued a "Buy" rating on 10/31/2025
- Leerink Partners issued a "Outperform" rating on 08/12/2025
To track analyst ratings and price targets for CARDINAL HEALTH, check out Quiver Quantitative's $CAH forecast page.
CARDINAL HEALTH Price Targets
Multiple analysts have issued price targets for $CAH recently. We have seen 10 analysts offer price targets for $CAH in the last 6 months, with a median target of $222.5.
Here are some recent targets:
- Erin Wright from Morgan Stanley set a target price of $245.0 on 01/29/2026
- Stephen Baxter from Wells Fargo set a target price of $237.0 on 01/15/2026
- Daniel Grosslight from Citigroup set a target price of $244.0 on 01/09/2026
- Glen Santangelo from Barclays set a target price of $243.0 on 12/09/2025
- Steven Valiquette from Mizuho set a target price of $210.0 on 11/04/2025
- Charles Rhyee from TD Cowen set a target price of $225.0 on 11/03/2025
- Elizabeth Anderson from Evercore ISI Group set a target price of $220.0 on 10/31/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
